Colleen Youngblood is a bilingual marketing strategist with nine years of experience in a highly regulated environment in both life sciences and healthcare advertising. She has expertise in physician-directed marketing and direct-to-consumer marketing, with a focus on digital initiatives. Her marketing style is passionate and off-the-beaten-path, which drives innovation, team motivation, and customer loyalty. Youngblood is adept at coaching and mentoring high-performing teams, and she has experience in multiple therapeutic areas, both specialized and GP-focused.

Youngblood holds a degree in Neuroscience and a minor in Psychology from McGill University, and she has completed Intro to Project Management at the same institution. She studied Teaching English at Oxford Seminars.

Youngblood has experience in Multi-Channel marketing in the US and Canada, and she has worked on the following brands: Celebrex, Chantix, Concerta, Duodopa, Enbrel, Gilenya, Lyrica, Lipitor, Neulasta, Nucynta, Nplate, Pristiq, and Tasigna. She is currently the Global Marketing Director at Omnipresence Technologies, and she previously worked as a Senior Account Executive at CDM Montreal and as a Senior Program Manager at Indegene.